Systemic but Not Local Infections Elicit Immunosuppressive IL-10 Production by Natural Killer Cells

Cell Host and Microbe

Volumn 6, Issue 6, 2009, Pages 503-512

  Perona Wright, Georgia ^a   Mohrs, Katja ^a   Szaba, Frank M ^a   Kummer, Lawrence W ^a   Madan, Rajat ^b   Karp, Christopher L ^b   Johnson, Lawrence L ^a   Smiley, Stephen T ^a   Mohrs, Markus ^a  

^a TRUDEAU INSTITUTE   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

MICROBIO; MOLIMMUNO

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INNATE IMMUNITY; LYMPHOCYTE FUNCTION; MOUSE; NATURAL KILLER CELL; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; T CELL DEPLETION; TOXOPLASMOSIS;

ANIMALS; CELLS, CULTURED; GENE EXPRESSION; IMMUNOSUPPRESSIVE AGENTS; INFECTION; INTERLEUKIN-10; INTERLEUKIN-12; KILLER CELLS, NATURAL; LISTERIA MONOCYTOGENES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; TOXOPLASMA; YERSINIA PESTIS;

MUS;

EID: 75149188275     PISSN: 19313128     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chom.2009.11.003     Document Type: Article

References (57)

1. Akuffo H., Alexis A., Eidsmo L., Saed A., Nylen S., and Maasho K. Natural killer cells in cross-regulation of IL-12 by IL-10 in Leishmania antigen-stimulated blood donor cells. Clin. Exp. Immunol. 117 (1999) 529-534
2. Anderson C.F., Oukka M., Kuchroo V.J., and Sacks D. CD4+CD25-Foxp3- Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J. Exp. Med. 204 (2007) 285-297
3. Bajenoff M., Breart B., Huang A.Y., Qi H., Cazareth J., Braud V.M., Germain R.N., and Glaichenhaus N. Natural killer cell behavior in lymph nodes revealed by static and real-time imaging. J. Exp. Med. 203 (2006) 619-631
4. Barkhausen T., Frerker C., Putz C., Pape H.C., Krettek C., and van Griensven M. Depletion of NK cells in a murine polytrauma model is associated with improved outcome and a modulation of the inflammatory response. Shock 30 (2008) 401-410
5. Belkaid Y. Regulatory T cells and infection: a dangerous necessity. Nat. Rev. Immunol. 7 (2007) 875-888
6. Chakir H., Lemay A.M., and Webb J.R. Cytokine expression by murine DX5+ cells in response to IL-12, IL-18, or the combination of IL-12 and IL-18. Cell. Immunol. 212 (2001) 71-81
7. Cohen J. The immunopathogenesis of sepsis. Nature 420 (2002) 885-891
8. Cooper M.A., Fehniger T.A., Turner S.C., Chen K.S., Ghaheri B.A., Ghayur T., Carson W.E., and Caligiuri M.A. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood 97 (2001) 3146-3151
9. Corinti S., Albanesi C., la Sala A., Pastore S., and Girolomoni G. Regulatory activity of autocrine IL-10 on dendritic cell functions. J. Immunol. 166 (2001) 4312-4318
10. Couper K.N., Blount D.G., and Riley E.M. IL-10: the master regulator of immunity to infection. J. Immunol. 180 (2008) 5771-5777
11. De Maria A., Fogli M., Mazza S., Basso M., Picciotto A., Costa P., Congia S., Mingari M.C., and Moretta L. Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients. Eur. J. Immunol. 37 (2007) 445-455
12. Deniz G., Erten G., Kucuksezer U.C., Kocacik D., Karagiannidis C., Aktas E., Akdis C.A., and Akdis M. Regulatory NK cells suppress antigen-specific T cell responses. J. Immunol. 180 (2008) 850-857
13. Etogo A.O., Nunez J., Lin C.Y., Toliver-Kinsky T.E., and Sherwood E.R. NK but not CD1-restricted NKT cells facilitate systemic inflammation during polymicrobial intra-abdominal sepsis. J. Immunol. 180 (2008) 6334-6345
14. Fillatreau S., Sweenie C.H., McGeachy M.J., Gray D., and Anderton S.M. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3 (2002) 944-950
15. Gazzinelli R.T., Wysocka M., Hayashi S., Denkers E.Y., Hieny S., Caspar P., Trinchieri G., and Sher A. Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 153 (1994) 2533-2543
16. Gazzinelli R.T., Wysocka M., Hieny S., Scharton-Kersten T., Cheever A., Kuhn R., Muller W., Trinchieri G., and Sher A. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J. Immunol. 157 (1996) 798-805
17. Goldszmid R.S., Bafica A., Jankovic D., Feng C.G., Caspar P., Winkler-Pickett R., Trinchieri G., and Sher A. TAP-1 indirectly regulates CD4+ T cell priming in Toxoplasma gondii infection by controlling NK cell IFN-gamma production. J. Exp. Med. 204 (2007) 2591-2602
18. Grant L.R., Yao Z.J., Hedrich C.M., Wang F., Moorthy A., Wilson K., Ranatunga D., and Bream J.H. Stat4-dependent, T-bet-independent regulation of IL-10 in NK cells. Genes Immun. 9 (2008) 316-327
19. Guan H., Moretto M., Bzik D.J., Gigley J., and Khan I.A. NK cells enhance dendritic cell response against parasite antigens via NKG2D pathway. J. Immunol. 179 (2007) 590-596
20. Hiromatsu T., Yajima T., Matsuguchi T., Nishimura H., Wajjwalku W., Arai T., Nimura Y., and Yoshikai Y. Overexpression of interleukin-15 protects against Escherichia coli-induced shock accompanied by inhibition of tumor necrosis factor-alpha-induced apoptosis. J. Infect. Dis. 187 (2003) 1442-1451
21. Hunter C.A. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat. Rev. Immunol. 5 (2005) 521-531
22. Jankovic D., Kullberg M.C., Feng C.G., Goldszmid R.S., Collazo C.M., Wilson M., Wynn T.A., Kamanaka M., Flavell R.A., and Sher A. Conventional T-bet+Foxp3- Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J. Exp. Med. 204 (2007) 273-283
23. Jansen P.M., van der Pouw Kraan T.C., de Jong I.W., van Mierlo G., Wijdenes J., Chang A.A., Aarden L.A., Taylor Jr. F.B., and Hack C.E. Release of interleukin-12 in experimental Escherichia coli septic shock in baboons: relation to plasma levels of interleukin-10 and interferon-gamma. Blood 87 (1996) 5144-5151
24. Johnson L.L., Berggren K.N., Szaba F.M., Chen W., and Smiley S.T. Fibrin-mediated protection against infection-stimulated immunopathology. J. Exp. Med. 197 (2003) 801-806
25. Kamanaka M., Kim S.T., Wan Y.Y., Sutterwala F.S., Lara-Tejero M., Galan J.E., Harhaj E., and Flavell R.A. Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse. Immunity 25 (2006) 941-952
26. Katakura T., Miyazaki M., Kobayashi M., Herndon D.N., and Suzuki F. CCL17 and IL-10 as effectors that enable alternatively activated macrophages to inhibit the generation of classically activated macrophages. J. Immunol. 172 (2004) 1407-1413
27. Li M.O., and Flavell R.A. Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10. Immunity 28 (2008) 468-476
28. Loza M.J., and Perussia B. Final steps of natural killer cell maturation: a model for type 1-type 2 differentiation?. Nat. Immunol. 2 (2001) 917-924
29. MacDonald A.S., Straw A.D., Bauman B., and Pearce E.J. CD8- dendritic cell activation status plays an integral role in influencing Th2 response development. J. Immunol. 167 (2001) 1982-1988
30. Madan R., Demircik F., Surianarayanan S., Allen J.L., Divanovic S., Trompette A., Yogev N., Gu Y., Khodoun M., Hildeman D., et al. Nonredundant roles for B cell-derived IL-10 in immune counter-regulation. J. Immunol. 183 (2009) 2312-2320
31. Magram J., Connaughton S.E., Warrier R.R., Carvajal D.M., Wu C.Y., Ferrante J., Stewart C., Sarmiento U., Faherty D.A., and Gately M.K. IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity 4 (1996) 471-481
32. Maroof A., Beattie L., Zubairi S., Svensson M., Stager S., and Kaye P.M. Posttranscriptional regulation of il10 gene expression allows natural killer cells to express immunoregulatory function. Immunity 29 (2008) 295-305
33. Martin-Fontecha A., Thomsen L.L., Brett S., Gerard C., Lipp M., Lanzavecchia A., and Sallusto F. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat. Immunol. 5 (2004) 1260-1265
34. Mayer K.D., Mohrs K., Crowe S.R., Johnson L.L., Rhyne P., Woodland D.L., and Mohrs M. The functional heterogeneity of type 1 effector T cells in response to infection is related to the potential for IFN-{gamma} production. J. Immunol. 174 (2005) 7732-7739
35. Maynard C.L., Harrington L.E., Janowski K.M., Oliver J.R., Zindl C.L., Rudensky A.Y., and Weaver C.T. Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10. Nat. Immunol. 8 (2007) 931-941
36. Mehrotra P.T., Donnelly R.P., Wong S., Kanegane H., Geremew A., Mostowski H.S., Furuke K., Siegel J.P., and Bloom E.T. Production of IL-10 by human natural killer cells stimulated with IL-2 and/or IL-12. J. Immunol. 160 (1998) 2637-2644
37. Mohrs K., Harris D.P., Lund F.E., and Mohrs M. Systemic dissemination and persistence of th2 and type 2 cells in response to infection with a strictly enteric nematode parasite. J. Immunol. 175 (2005) 5306-5313
38. Moore K.W., de Waal Malefyt R., Coffman R.L., and O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19 (2001) 683-765
39. Moretta A. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat. Rev. Immunol. 2 (2002) 957-964
40. Mullarky I.K., Szaba F.M., Berggren K.N., Parent M.A., Kummer L.W., Chen W., Johnson L.L., and Smiley S.T. Infection-stimulated fibrin deposition controls hemorrhage and limits hepatic bacterial growth during listeriosis. Infect. Immun. 73 (2005) 3888-3895
41. Parent M.A., Berggren K.N., Kummer L.W., Wilhelm L.B., Szaba F.M., Mullarky I.K., and Smiley S.T. Cell-mediated protection against pulmonary Yersinia pestis infection. Infect. Immun. 73 (2005) 7304-7310
42. Peritt D., Robertson S., Gri G., Showe L., Aste-Amezaga M., and Trinchieri G. Differentiation of human NK cells into NK1 and NK2 subsets. J. Immunol. 161 (1998) 5821-5824
43. Perona-Wright G., Anderton S.M., Howie S.E., and Gray D. IL-10 permits transient activation of dendritic cells to tolerize T cells and protect from central nervous system autoimmune disease. Int. Immunol. 19 (2007) 1123-1134
44. Philipovskiy A.V., and Smiley S.T. Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection. Infect. Immun. 75 (2007) 878-885
45. Portielje J.E., Lamers C.H., Kruit W.H., Sparreboom A., Bolhuis R.L., Stoter G., Huber C., and Gratama J.W. Repeated administrations of interleukin (IL)-12 are associated with persistently elevated plasma levels of IL-10 and declining IFN-gamma, tumor necrosis factor-alpha, IL-6, and IL-8 responses. Clin. Cancer Res. 9 (2003) 76-83
46. Roers A., Siewe L., Strittmatter E., Deckert M., Schluter D., Stenzel W., Gruber A.D., Krieg T., Rajewsky K., and Muller W. T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation. J. Exp. Med. 200 (2004) 1289-1297
47. Sherwin C., Broadbent R., Young S., Worth J., McCaffrey F., Medlicott N.J., and Reith D. Utility of interleukin-12 and interleukin-10 in comparison with other cytokines and acute-phase reactants in the diagnosis of neonatal sepsis. Am. J. Perinatol. 25 (2008) 629-636
48. Shinkai Y., Rathbun G., Lam K.P., Oltz E.M., Stewart V., Mendelsohn M., Charron J., Datta M., Young F., and Stall A.M. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68 (1992) 855-867
49. Slifka M.K., Pagarigan R.R., and Whitton J.L. NK markers are expressed on a high percentage of virus-specific CD8+ and CD4+ T cells. J. Immunol. 164 (2000) 2009-2015
50. Stetson D.B., Mohrs M., Reinhardt R.L., Baron J.L., Wang Z.E., Gapin L., Kronenberg M., and Locksley R.M. Constitutive cytokine mRNAs mark Natural Killer (NK) and NK T cells poised for rapid effector function. J. Exp. Med. 198 (2003) 1069-1076
51. Stumhofer J.S., Silver J.S., Laurence A., Porrett P.M., Harris T.H., Turka L.A., Ernst M., Saris C.J., O'Shea J.J., and Hunter C.A. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat. Immunol. 8 (2007) 1363-1371
52. Sun J., Madan R., Karp C.L., and Braciale T.J. Effector T cells control lung inflammation during acute Influenza virus infection by producing IL-10. Nat. Med. 15 (2009) 277-284
53. Suzuki Y., Orellana M.A., Schreiber R.D., and Remington J.S. Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science 240 (1988) 516-518
54. Suzuki Y., Sher A., Yap G., Park D., Neyer L.E., Liesenfeld O., Fort M., Kang H., and Gufwoli E. IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following peroral infection with Toxoplasma gondii. J. Immunol. 164 (2000) 5375-5382
55. Tripp C.S., Gately M.K., Hakimi J., Ling P., and Unanue E.R. Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice. Reversal by IFN-gamma. J. Immunol. 152 (1994) 1883-1887
56. Vosshenrich C.A., Garcia-Ojeda M.E., Samson-Villeger S.I., Pasqualetto V., Enault L., Richard-Le Goff O., Corcuff E., Guy-Grand D., Rocha B., Cumano A., et al. A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127. Nat. Immunol. 7 (2006) 1217-1224
57. Wu C., Wang X., Gadina M., O'Shea J.J., Presky D.H., and Magram J. IL-12 receptor beta 2 (IL-12R beta 2)-deficient mice are defective in IL-12-mediated signaling despite the presence of high affinity IL-12 binding sites. J. Immunol. 165 (2000) 6221-6228